Profile
Mark Andersen worked as an Investments Director-Pension Plan at Eli Lilly & Co. from 2004 to 2015.
He then served as Vice President-Finance & Controller at MiMedx, Inc. in 2015 and 2016.
Mark also worked as an Auditor at Deloitte Development LLC from 1998 to 1999 and at KPMG US LLP from 1996 to 1998.
He held the position of Chief Financial Officer & VP-Administration at Indiana Biosciences Research Institute from 2016 to 2022.
Currently, Mark is the Chief Financial Officer at FibroBiologics, Inc. since 2022.
Mr. Andersen completed his undergraduate and graduate degrees at Southern Utah University and holds an MBA from Stephen M.
Ross School of Business.
Former positions of Mark Andersen
| Companies | Position | End |
|---|---|---|
| FIBROBIOLOGICS, INC. | Director of Finance/CFO | 2024-10-27 |
Indiana Biosciences Research Institute
Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-commercial research organization | Director of Finance/CFO | 2022-04-30 |
MiMedx, Inc.
MiMedx, Inc. Medical SpecialtiesHealth Technology Develops orthopedic implant products | Director of Finance/CFO | 2016-01-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2015-07-31 |
Deloitte Development LLC
Deloitte Development LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and tax services | Comptroller/Controller/Auditor | 1998-12-31 |
Training of Mark Andersen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
MiMedx, Inc.
MiMedx, Inc. Medical SpecialtiesHealth Technology Develops orthopedic implant products | Health Technology |
Southern Utah University
Southern Utah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly USA LLC
Lilly USA LLC Pharmaceuticals: MajorHealth Technology Lilly USA LLC engages in the provision of pharmaceutical services. The company was founded on July 15, 2008 and is headquartered in Indianapolis, IN. | Health Technology |
Deloitte Development LLC
Deloitte Development LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and tax services | Commercial Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana Biosciences Research Institute
Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-commercial research organization | Commercial Services |
KPMG US LLP
KPMG US LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing and taxation services | Commercial Services |
FibroBiologics, Inc.
FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
- Stock Market
- Insiders
- Mark Andersen
















